Searched for
NOMURA TARGET PRICE DR LAL
Dr Lal PathLabs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?Dr Lal PathLabs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages including Nomu...- Buy, Sell or Hold: Anand Rathi maintains buy on Bansal Wire; Equirus Securities recommends buy on Greenply IndustriesAnand Rathi and Equirus Securities remain bullish on select stocks with strong earnings visibility. Anand Rathi maintained a 'Buy' on Bansa...
- Tata Consumer shares jump 3% after Q1 results. Here’s why Nomura, Motilal see strong upside potentialTata Consumer Products shares rose 3% after the FMCG major reported a 27.8% YoY jump in Q1 FY27 net profit to Rs 427 crore, while revenue i...
- Stocks to buy in 2026 for long term: Dr Lal PathLabs, IDFC First Bank among 5 stocks that could give 10-30% returnNuvama has reiterated its 'Buy' rating on Dr Lal PathLabs and raised the target price to Rs 2,140 from Rs 1,900, implying a potential upsid...
- US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipelineIndian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...
- Two Trades for Today: A diagnostics major for a 6% rise, a large-cap financial service stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Infosys shares fall 3% as JPMorgan downgrades stock, Jefferies cuts target after Q1 resultsInfosys shares fell after global brokerages turned cautious following the company's Q1 FY27 results and a cut to the upper end of its reven...
- HDFC Bank shares slide 10% in four days after Q1 results but brokerages see up to 40% upside. Here’s whyHDFC Bank shares have fallen nearly 10% in four sessions since its Q1 FY27 results despite reporting steady earnings growth. Brokerages rem...
- Buy, Sell or Hold? Goldman Sachs maintains a buy on Eternal; Citi recommends sell rating on Dr Reddy’s Laboratories post Q1 resultsGoldman Sachs and Citi have issued fresh post-Q1 calls on three stocks. Goldman stays bullish on Eternal (Buy, target Rs 345, 21% upside) d...
- Dr Reddy’s shares crack 9% after weak Q1; these 3 brokerages slash their target pricesDr Reddy’s shares plunged 9% on Thursday after the drugmaker reported a weak Q1 FY27 performance, with net profit tumbling 69% year-on-year...
- Eternal shares jump 3% after Q1 results. Jefferies, CLSA and 4 other brokerages weigh inShares of Eternal climbed 3% after its Q1FY27 earnings, with brokerages reaffirming bullish views on the stock. JPMorgan, CLSA, Jefferies, ...
- MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1...
- Profit up 35%, shares down 15%: What went wrong at Bandhan Bank?Bandhan Bank shares hit the 15% lower circuit despite a 35% jump in Q1 profit, as investors focused on the lender's sharp cut to its FY27 R...
- HDFC Bank shares fall for 2nd day but Jefferies, others brokerages remain bullish. Should you buy the dip?HDFC Bank shares extended losses for a second straight session after its Q1 FY27 earnings, but brokerages remain optimistic on the stock. J...
- Triveni Engineering demerger: Last day to buy stock to get Triveni Power Transmission shares. Check detailsThe company, which is associated with the production of sugar and ethanol along with engineering works, announced earlier this year that as...
- HDFC Bank shares crash 5%, wipe off Rs 70,000 cr from investor wealth. Why Jefferies, Nomura, others see up to 28% upside?HDFC Bank shares fell sharply on Monday after its Q1FY27 earnings failed to impress investors, wiping out nearly Rs 70,000 crore in market ...
- Reliance Industries share price target: What are brokerages saying after Q1 results?Reliance Industries shares gained after the conglomerate reported better-than-expected June quarter earnings, driven by robust growth acros...
- 8 Sensex stocks with up to 30% upside potential. Are these in your portfolio?
- 2 reasons why Infosys, TCS and other IT stocks are rising todayIndian IT stocks saw gains on Friday, led by Tech Mahindra's better-than-expected first quarter results. Infosys and HCL Tech also advanced...
- Tech Mahindra shares jump 3% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages now expectTech Mahindra shares surged after the IT major reported better-than-expected Q1 FY27 results, with net profit rising 28% YoY to Rs 1,465 cr...
Load More
